Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Rat Study Suggests Gadolinium Injections May Leave Deposits in Brain

A recent study involving rats is adding to concerns that toxic gadolinium deposits may accumulate in the body – specifically the brain – following the administration of certain MRI contrast dyes. FDA Gadolinium Retention Warning Gadolinium-based MRI contrast dyes are … Continue reading

Proton Pump Inhibitor Lawsuits: Stipulation to Toll Statute of Limitations Filed for Kidney Injury Claims

Individuals who suffered kidney failure and other renal complications allegedly related to the long-term use of Nexium and other proton pump inhibitors may have more time to file their claims, so long as they meet requirements of a stipulation recently … Continue reading

Johnson & Johnson Hit with $4.7 Billion Talcum Powder Ovarian Cancer Verdict

A Missouri jury has ordered Johnson & Johnson to pay a total of $4.7 billion to 22 women or their survivors, after finding that the company failed to warn consumers that long-term use of the its popular talcum powder products … Continue reading

Federal Court Overseeing C.R. Bard IVC Filter Lawsuits to Convene Additional Bellwether Trials

The federal court overseeing thousands of IVC filter lawsuits involving devices manufactured by C.R. Bard, Inc. is preparing to hold three additional bellwether trials beginning in the Fall. According to a Case Management Order issued in the U.S. District Court, … Continue reading

FDA Announces New Side Effects Warnings for Levaquin, Other Fluoroquinolone Antibiotics

Levaquin and other fluoroquinolone antibiotics have been associated with serious mental health side effects, as well as severe blood sugar disturbances, prompting the U.S. Food & Drug Administration (FDA) to update the drugs’ prescribing information yet again. What is the … Continue reading

Thousands of Risperdal Lawsuits at Stake in Upcoming Appeal

The fate of thousands of Risperdal lawsuits is now in the hands of the Pennsylvania Supreme Court, which has agreed to hear an appeal on whether some cases should be time barred. Trial Court Set June 30, 2009 as Deadline … Continue reading

Nexium Lawsuit News: Federal Court Overseeing Proton Pump Inhibitor Kidney Claims Schedules First Bellwether Trial

The federal court overseeing thousands of kidney injury lawsuits filed against the manufacturers of Nexium and other proton pump inhibitors will convene the litigation’s first bellwether trial on September 21, 2020. According to an Order issued in the U.S. District … Continue reading

Pennsylvania Judge Urges Appeals Court to Uphold $70 Million Risperdal Lawsuit Verdict

A Pennsylvania judge has urged the state’s Superior Court to uphold a $70 million verdict awarded to a Risperdal gynecomastia plaintiff in 2016. Verdict Is Larges Awarded in Pennsylvania Risperdal Litigation The case was the fifth to be tried in … Continue reading

Extended Use of Proton Pump Inhibitors May Up Pneumonia Risk in Older Adults

People over the age of 60 who use a class of heart burn drugs called proton pump inhibitors longer than a year may face a higher risk of pneumonia, according to the results of a recent study. Risks of Long-Term … Continue reading

Study Suggests Gadolinium MRI Contrast Dyes Accumulate in Marine Ecosystems

A group of researchers have suggested that gadolinium MRI contrast dyes are accumulating in certain marine ecosystems, which could ultimately have consequences for human health. Gadolinium is used in MRI contrast dyes to improve the visibility of organs, tumors, and … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content